New evidence that malaria drug has no antiviral effect on COVID-19
In a new study, researchers examined the antiviral effect of hydroxychloroquine in macaques (a type of monkey) infected with the COVID-19 virus, used alone...
COVID-19 antibodies may be stable in body for two months after diagnosis
In a new study, researchers found that COVID-19 antibodies remain stable in the blood of the majority of infected individuals almost two months after...
Planes, trains and automobiles: Reducing your COCVID-19 risk in traveling
After enduring more than two months of quarantine, businesses and institutions are reopening, spurring summer travel plans to satisfy the urge to escape confinement.
But...
Gut problems are common in people with COVID-19
In a new study, researchers found that approximately 12% of patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection report gut symptoms.
The research...
Human antibodies could protect against COVID-19, new study shows
In a new study, researchers found has discovered antibodies in the blood of recovered COVID-19 patients that provide powerful protection against SARS-CoV-2, the coronavirus...
Scientists find new way to speed search for COVID-19 drugs, vaccines
The global effort to quickly develop drugs and vaccines for COVID-19 has been hampered by limited numbers of laboratory mice that are susceptible to...
How to care for your loved ones with COVID-19 at home
Much has been reported about some of the most severe cases of COVID-19, but what about those who may be experiencing mild or lesser...
Self-swabbing tests for COVID-19 accurate and safe, Stanford study shows
In a new study, researchers found that test samples collected by people who swabbed their own nasal passages yielded results for the COVID-19 virus...
COVID-19 virus is mutating slowly, and that’s a good thing
Viruses evolve over time, undergoing genetic changes, or mutations, in their quest to survive.
Some viruses produce many variations, others only a few. Fortunately, SARS-CoV-2,...
This arthritis drug shows promise against COVID-19
In a new study, researchers found that a drug against rheumatoid arthritis called baricitinib could potentially be repurposed to treat patients with COVID-19.
The findings...